AzTrials
AzTrials

Postoperative; Dysfunction Following Cardiac SurgeryNCT02846818

Cerebral Energy State in Cardiac Surgery

A study testing Microdialysis in people with Postoperative; Dysfunction Following Cardiac Surgery, run by Odense University Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Impaired cerebral function remains an important complication of cardiopulmonary bypass (CPB) during cardiac surgery. The aim of the present study is to investigate whether the lactate to pyruvate (LP) ratio obtained by microdialysis (MD) of the cerebral venous outflow reflects a derangement of global cerebral energy… Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
Microdialysis
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteDenmark
Study dates
Feb 2015to May 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective CABG on CPB

Who cannot join

  • Acute patients or reoperations
  • Patients with epidural catheter
  • Previous stroke
  • Stenotic carotids
  • Ejection fraction (EF) < 50 %
  • Estimated per operative risk > 5%

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Odense University Hospital

    Odense, Fyn, 5000

Other trials in Denmark

About this study

Official title: Continuous Monitoring of Cerebral Energy State During Cardiac Surgery - A Novel Approach Utilizing Intravenous Microdialysis

Impaired cerebral function remains an important complication of cardiopulmonary bypass (CPB) during cardiac surgery. The aim of the present study is to investigate whether the lactate to pyruvate (LP) ratio obtained by microdialysis (MD) of the cerebral venous outflow reflects a derangement of global cerebral energy state during cardiopulmonary bypass.

Read the detailed description

Patients undergoing primary, elective coronary artery bypass grafting were blindly randomized to usual range MAP (40 to 60 mmHg; n = 5) or intervention group MAP (60 to 80 mmHg; n = 5) during CPB. MD catheters were positioned in a retrograde direction in the internal jugular vein and a reference catheter was inserted into the brachial artery. The relations between LP ratio, MAP, data obtained from bi-frontal NIRS and neurological outcome measures were assessed.

Being tested
Microdialysis
Keywords
Microdialysis, Cardiac surgery, Lactate to pyruvate ratio, Cardiopulmonary bypass, Neurological complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MicrodialysisProcedure or surgery

    Also called MMSE, NIRS

    Extracerebral MD catheters were positioned in a retrograde direction in the internal jugular vein.

Study groups in NCT02846818
Study groupRoleWhat they receive
Low mean arterial perfusion pressureExperimental5 patients undergoing primary, elective coronary artery bypass grafting were randomized to usual range MAP (40 to 60 mmHg) during CPB. Microdialysis catheters were positioned in a retrograde direction in the internal jugular vein.
Receives: Procedure: Microdialysis
High mean arterial perfusion pressureExperimental5 patients undergoing primary, elective coronary artery bypass grafting were blindly randomized to intervention group MAP (60 to 80 mmHg) during CPB. Microdialysis catheters were positioned in a retrograde direction in the internal jugular vein.
Receives: Procedure: Microdialysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Extracerebral microdialysis parameters

    Does the LP ratio of cerebral venous blood increase significantly during CPB indicating compromised cerebral oxidative metabolism.The analyses included the variables routinely monitored during intracerebral microdialysis: glucose, pyruvate, lactate, glutamate, glycerol and lactate to pyruvate ratio.

    Measured: MD parameters were measured intraoperatively and for two hours postoperatively

Secondary outcomes (2)
  1. Mini mental state examination (MMSE)

    Patients were assessed preoperatively and postoperatively day two after surgery

    Measured: Neurological complications with in 2 days after surgery

  2. Near-infrared spectroscopy (NIRS)

    Right and left frontal rSO2 values were recorded simultaneously pre- and intraoperatively and for two hours postoperatively. Cerebral desaturation was defined as a decrease in the relative rSO2 value of 20 % compared with the individual pre-induction baseline value

    Measured: one day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2016 (estimated)
  2. Study startFeb 2015
  3. Primary completionApr 2015
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02846818
Sponsor's protocol ID
S-20130166
Status last verified
Jul 2016
First submitted
19 Jul 2016
Last updated
27 Jul 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided: Undecided

Publications

  • Ahonen J, Salmenpera M. Brain injury after adult cardiac surgery. Acta Anaesthesiol Scand. 2004 Jan;48(1):4-19. doi: 10.1111/j.1399-6576.2004.00275.x.

    PubMed 14674968
  • McDonagh DL, Berger M, Mathew JP, Graffagnino C, Milano CA, Newman MF. Neurological complications of cardiac surgery. Lancet Neurol. 2014 May;13(5):490-502. doi: 10.1016/S1474-4422(14)70004-3. Epub 2014 Apr 2.

    PubMed 24703207

Questions about this trial

What is this clinical trial studying?

A study testing Microdialysis in people with Postoperative; Dysfunction Following Cardiac Surgery, run by Odense University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Extracerebral microdialysis parameters (time frame: MD parameters were measured intraoperatively and for two hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02846818, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in